Clin2
NCT07620938Possibly a fitRecruiting

TJ0113 capsule for treating muscle loss in older adults

Sarcopenia

Treatments studied

Part of Brain & nervous system clinical trials.

This study tests a new capsule called TJ0113 to see if it can help older adults with sarcopenia (muscle loss) improve their muscle strength and physical function. It's a phase 2 study, meaning the drug is being tested for safety and effectiveness.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
204 people
Ages
60 years and older
Study type
Interventional

Who can take part

  • You are 60 years old or older.
  • You have been diagnosed with sarcopenia, meaning you have low muscle mass plus low grip strength or slow walking speed.
  • You can walk 400 meters (about a quarter mile) within 15 minutes without sitting down or using a walker or cane.
  • You have stable chronic conditions (like high blood pressure or diabetes) that are well-controlled with medication.
  • You do not have severe heart or kidney problems, uncontrolled high blood pressure, or recent strokes or heart attacks.
  • You are not taking medications that affect muscle metabolism (except for stable doses of denosumab or calcium/vitamin D).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06537115Recruiting· Phase 4
Vitamin D, protein, and exercise for muscle loss

This trial tests whether a combination of a vitamin D-like drug (idecalcitol), whey protein powder, and a structured exercise program can help rebuild muscle strength and mass in people with sarcopenia. It lasts about 6 months.

Hangzhou, Zhejiang
NCT07072195Recruiting· Phase 2
A study of AMC6156 for people with muscle loss

This trial tests an investigational drug called AMC6156 to see if it can help improve muscle mass and strength in older adults with sarcopenia (age-related muscle loss). Participants will also follow exercise and nutrition guidance.

Seongnam-si, Gyeonggi-do
NCT07808905Not yet recruiting· Phase 1/Phase 2
Stem cell treatment for age-related muscle loss

This study tests an experimental treatment called EN001, made from stem cells, to see if it can help improve muscle strength and function in older adults with sarcopenia. Participants will receive the treatment or a placebo, and all will follow a diet and exercise program.

Seoul
NCT07321535Not yet recruiting
Herbal formula and exercise for muscle loss in older adults

This trial tests whether a traditional Chinese herbal formula (Huangjing Yangji) combined with resistance exercise helps improve muscle mass and strength in older adults with sarcopenia. If you have been diagnosed with sarcopenia and fit the age range, this could be a chance to try a combined approach.

Beijing, Beijing Municipality
NCT05978206Recruiting· Phase 2
Strength, muscle mass, and nutrition therapy for older adults with sarcopenia

This study tests if a combination of a medicine (nandrolone), physical therapy, and a special diet can help older adults with muscle loss (sarcopenia) improve their strength and muscle mass. It is for people age 60 to 99 who have been diagnosed with sarcopenia based on specific muscle strength and mass measurements.

Warsaw, Masovian Voivodeship
NCT07749118Recruiting
Study of HB05P for muscle health in older adults

This study tests a food product called HB05P to see if it can help improve muscle strength and physical function in people with low muscle mass. It includes a supervised exercise program and may help you maintain independence as you age.

Yangsan

Hear when a new Sarcopenia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.